Activation of NF-κB signaling, observed in most cancers, has been shown to contribute to cancer occurrence and progression by regulating multiple processes, including cell survival and proliferation, EMT (epithelial to mesenchymal transition), inflammation, and angiogenesis, as well as metastasis19, 20. This evidence concerns the gene NFKB1 and cancer.